Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Idarubicin |
Synonyms | |
Therapy Description |
Idarubicin is an anthracycline, which inhibits DNA replication thereby preventing RNA and protein synthesis (NCI Drug Dictionary). Idarubicin, in combination with other approved drugs, is FDA approved for acute myelogenous leukemia (FDA.gov). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Idarubicin | Idamycin | Idarubicin Hcl | Chemotherapy - Anthracycline 11 | Idarubicin is an anthracycline, which inhibits DNA replication thereby preventing RNA and protein synthesis and, in combination with other approved drugs, is FDA approved for acute myelogenous leukemia (FDA.gov). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|